Ángel López-Nicolás1, Marta Trapero-Bertran2,3, Celia Muñoz3. 1. Economics Department, Faculty of Business Science, Universidad Politécnica de Cartagena (UPCT), C/Real, 3, 30201, Cartagena (Murcia), Spain. angel.lopez@upct.es. 2. Faculty of Economic and Social Sciences, Universitat Internacional de Catalunya (UIC), C/Immaculada, 22, 08017, Barcelona, Spain. 3. Centre de Recerca en Economia i Salut (CRES), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Abstract
BACKGROUND AND AIMS: The economic evaluation of tobacco control policies requires the adoption of assumptions about the impact of changes in smoking status on health-related quality of life (HRQoL). Estimates for such impacts are necessary for different populations. This paper aims to test whether smoking status has an independent effect on HRQoL over and above the effect derived from the increased likelihood of suffering a tobacco related disease, and to calculate utility values for the Spanish population. METHODS: Using data from the Spanish Encuesta Nacional de Salud of 2011-12, we estimate statistical models for HRQoL as measured by the EQ-5D-5L instrument as a function of smoking status. We include a comprehensive set of controls for biological, clinical, lifestyle and socioeconomic characteristics. RESULTS: Smoking status has an independent, statistically significant effect on HRQoL. However, the size of the effect is small. The typical smoking related diseases, such as lung cancer, are associated with a reduction in HRQoL about 5 times larger than the difference between current smokers and never smokers. CONCLUSION: Attributing substantive HRQoL gains to quitting smoking as well as accounting for the concomitant HRQoL gain derived from a smaller likelihood of contracting tobacco related diseases might lead to an overestimation of the benefits of tobacco control policies. Nonetheless, the relatively large drops in HRQoL associated with being diagnosed with diseases that might be causally linked to tobacco suggest that such diseases should not be omitted from the economic evaluations of tobacco control policies.
BACKGROUND AND AIMS: The economic evaluation of tobacco control policies requires the adoption of assumptions about the impact of changes in smoking status on health-related quality of life (HRQoL). Estimates for such impacts are necessary for different populations. This paper aims to test whether smoking status has an independent effect on HRQoL over and above the effect derived from the increased likelihood of suffering a tobacco related disease, and to calculate utility values for the Spanish population. METHODS: Using data from the Spanish Encuesta Nacional de Salud of 2011-12, we estimate statistical models for HRQoL as measured by the EQ-5D-5L instrument as a function of smoking status. We include a comprehensive set of controls for biological, clinical, lifestyle and socioeconomic characteristics. RESULTS: Smoking status has an independent, statistically significant effect on HRQoL. However, the size of the effect is small. The typical smoking related diseases, such as lung cancer, are associated with a reduction in HRQoL about 5 times larger than the difference between current smokers and never smokers. CONCLUSION: Attributing substantive HRQoL gains to quitting smoking as well as accounting for the concomitant HRQoL gain derived from a smaller likelihood of contracting tobacco related diseases might lead to an overestimation of the benefits of tobacco control policies. Nonetheless, the relatively large drops in HRQoL associated with being diagnosed with diseases that might be causally linked to tobacco suggest that such diseases should not be omitted from the economic evaluations of tobacco control policies.
Entities:
Keywords:
EQ-5D-5L; Economic evaluation; Quality of life; Smoking
Authors: Elisardo Becoña; Ma Isabel Vázquez; Ma del Carmen Míguez; Elena Fernández del Río; Ana López-Durán; Úrsula Martínez; Bárbara Piñeiro Journal: Psicothema Date: 2013
Authors: J Fernández de Bobadilla Osorio; C Sánchez-Maestre; M Brosa Riestra; O Arroyo; V Sanz de Burgoa; K Wilson Journal: An Med Interna Date: 2008-07
Authors: I-Chan Huang; Constantine Frangakis; Mark J Atkinson; Richard J Willke; Walter L Leite; W Bruce Vogel; Albert W Wu Journal: Health Serv Res Date: 2008-02 Impact factor: 3.402
Authors: Nicola E Stanczyk; Eline S Smit; Daniela N Schulz; Hein de Vries; Catherine Bolman; Jean W M Muris; Silvia M A A Evers Journal: PLoS One Date: 2014-10-13 Impact factor: 3.240
Authors: Juan M Ramos-Goñi; Jose L Pinto-Prades; Mark Oppe; Juan M Cabasés; Pedro Serrano-Aguilar; Oliver Rivero-Arias Journal: Med Care Date: 2017-07 Impact factor: 2.983
Authors: Bernard Le Foll; Megan E Piper; Christie D Fowler; Serena Tonstad; Laura Bierut; Lin Lu; Prabhat Jha; Wayne D Hall Journal: Nat Rev Dis Primers Date: 2022-03-24 Impact factor: 52.329
Authors: Tien V Tran; Hoang C Nguyen; Linh V Pham; Minh H Nguyen; Huu Cong Nguyen; Tung H Ha; Dung T Phan; Hung K Dao; Phuoc B Nguyen; Manh V Trinh; Thinh V Do; Hung Q Nguyen; Thao T P Nguyen; Nhan P T Nguyen; Cuong Q Tran; Khanh V Tran; Trang T Duong; Hai X Pham; Lam V Nguyen; Tam T Vo; Binh N Do; Thai H Duong; Minh Khue Pham; Thu T M Pham; Kien Trung Nguyen; Shwu-Huey Yang; Jane C J Chao; Tuyen Van Duong Journal: BMJ Open Date: 2020-12-07 Impact factor: 2.692